VANINasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Vivani Medical, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$1.12+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $97.54M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.57 (−33.73%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Vivani Medical, Inc. reported revenue of $0 for fiscal 2025. Free cash flow was -$26.50M.
Revenue
$0
FY2025
Operating income
-$27.23M
TTM Q2 2026
Free cash flow
-$26.50M
TTM Q2 2026
EPS, diluted
-$0.35
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Jun 30, 2026
Valuation
- Market cap
- $97.54M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 5.14
- Dividend yield
- –
- Free cash flow yield
- -27.17%
Fundamentals
- Revenue
- $0
- Net income
- -$26.31M
- EPS, diluted
- -$0.35
- Free cash flow
- -$26.50M
- Book value per share
- $0.22
- Diluted shares
- 87M
Fourteen years at a glance
Fiscal years 2012 to 2025 and trailing twelve months, USD
Revenue
–
Gross profit
–
Operating income
-$27.23M
Net income
-$26.31M
EPS, diluted
-$0.35
Free cash flow
-$26.50M
Reported periodTrailing twelve months